Reliable Commercial Funding operates as a commercial loan broker and intermediary that connects borrower inquiries to appropriate lenders from its network of 200+ partners nationwide. The company positions itself as an alternative to traditional banks and fintech lenders, targeting real estate investors, small business owners, and entrepreneurs seeking larger loan amounts and more flexible terms than conventional sources provide.
The company offers a comprehensive suite of commercial financing products including commercial real estate acquisition and refinancing loans, bridge loans for time-sensitive transactions, SBA 7(a) loans, hard money loans based on asset value rather than credit score, business lines of credit, and equipment financing up to $5M. Loan amounts range from $250K to $50M+, with a stated approval decision timeline of 24-48 hours. A 3.5% processing fee applies, payable via Zelle or credit card.
RCF differentiates itself through several claimed advantages: a "Triple listed refund term" promising advertised approval claims, guaranteed funding, and full fee refund if they don't deliver; a dedicated loan officer assigned to each deal; rapid decision timelines compared to traditional lenders; and access to a large lender network enabling approval for complex deals. The website displays 200+ verified client reviews with a 5.0 rating and cites specific case studies of closed deals ranging from $4.2M commercial acquisitions to equipment financing completed in 8 days.
Important caveats exist: the website contains placeholder statistics ("0+ Years Experience," "0+ Loans Closed," "$0M+ Total Funded"), indicating either incomplete profile data or a newer operation. The "advertised approval claims" and "Guaranteed Funding" claims are unverified and should be evaluated skeptically—such stated terms are uncommon in legitimate lending. The company charges a 3.5% upfront processing fee, which adds $7,500-$17,500+ to larger loans. As a broker rather than direct lender, borrowers are dependent on partner lender terms and approval criteria.